IL-9 Integrates the Host-Candida Cross-Talk in Vulvovaginal Candidiasis to Balance Inflammation and Tolerance
Vulvovaginal candidiasis (VVC) is a common fungal infection caused by Candida albicans. The antifungal therapy represents the standard of care but due to the high costs of treatment and to the inability to prevent recurrences, the development of alternative therapeutic approaches is much-awaited. Re...
Main Authors: | Giorgia Renga, Monica Borghi, Vasileios Oikonomou, Paolo Mosci, Andrea Bartoli, Jean-Christophe Renauld, Luigina Romani, Claudio Costantini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02702/full |
Similar Items
-
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk
by: Monica Borghi, et al.
Published: (2019-10-01) -
Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01) -
Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01) -
Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01) -
The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-06-01)